ABSTRACT Since their discovery as important determinants of virulence and growth, the type VII ESX secretion systems (ESX-1 to ESX-5) of slow-growing pathogenic mycobacteria have been the focus of intense scrutiny. Genetic studies have been instrumental in identifying the core components and substrates of these molecular secretion machines and have helped uncover the multifunctional properties of some of them. For instance, the mycosin MycP 1 of ESX-1, a membrane-associated subtilisin-like serine protease, was shown to have dual functions: the entire protein is essential for ESX-1 function, but only the serine protease regulates secretion activity. MycP 5 of ESX-5, on the other hand, is required for ESX-5 secretion activity, but the function of its predicted serine protease remains unknown. Recently, van Winden and colleagues (mBio 7:e01471-16, 2016, http://dx.doi.org/ 10.1128/mBio.01471-16) reported compelling evidence that MycP 1 and MycP 5 serve to stabilize the interactions of core ESX-1 and ESX-5 components, respectively, thus explaining how they facilitate the secretion activities of their associated systems.
M
ycobacteria have evolved specialized type VII secretion systems to transport molecular cargo across their thick and complex cell envelopes (1) . In slow-growing pathogenic mycobacteria, like Mycobacterium tuberculosis and Mycobacterium bovis, the causative agents of tuberculosis (TB), and Mycobacterium marinum, the agent of TB in fish and amphibians and a less hazardous surrogate model often used to study TB pathogenesis, there are five paralogous type VII secretion systems, called ESX-1 to ESX-5 (1) . All five share a set of common features, in that the genetic clusters encoding each ESX system contain genes for (i) small secreted proteins of about 100 amino acids with a conserved Trp-X-Gly (WXG) motif located in the middle of the polypeptide (e.g., EsxA of ESX-1, EsxN of ESX-5, etc.), (ii) one putative cell membrane-associated protein (e.g., EccB 1 of ESX-1, EccB 5 of ESX-5, etc.), (iii) transmembrane ATPases of the FtsK-SpoIIIE family (e.g., EccCa 1 and EccCb 1 of ESX-1, EccC 5 of ESX-5, etc.), (iv) one 11-transmembrane domain protein that presumably forms a channel in the mycobacterial cell membrane (e.g., EccD 1 of ESX-1, EccD 5 of ESX-5, etc.), (v) with the exception of ESX-4, another putative cell membrane-associated protein (e.g., EccE 1 of ESX-1, EccE 5 of ESX-5, etc.), and (vi) one subtilisin-like mycosin (e.g., MycP 1 of ESX-1, MycP 5 of ESX-5, etc.) (1) .
Of the five mycobacterial type VII secretion systems, ESX-1 has been the most studied and is reviewed in excellent detail elsewhere (1) . Briefly, ESX-1 in M. tuberculosis, M. bovis, and M. marinum is crucial for the secretion of its associated protein substrates (namely, EsxA, EsxB, EspA, EspB, and EspC) and for mediating virulence through an incredibly diverse number of ways (1) . Indeed, it was a spontaneous genetic deletion resulting in the inactivation of ESX-1 in a virulent isolate of M. bovis that set it on its inexorable march toward attenuation and the eventual derivation of the live TB vaccine M. bovis BCG (1, 2). ESX-3 has been implicated in metal homeostasis and is indispensable for M. tuberculosis growth in vitro and in vivo (1, (3) (4) (5) (1, (6) (7) (8) (9) . ESX-5 is also involved in modulating the host immune response to M. tuberculosis and M. marinum (1, (6) (7) (8) (9) . Meanwhile, ESX-2 and ESX-4 have remained uncharacterized (1) .
In the earliest study of M. tuberculosis mycosins, beginning in the year 2000, amino acid sequence analysis of its five MycP proteins led to the identification of an Asp-His-Ser catalytic triad also found in bacterial serine proteases of the subtilisin family (10) . Moreover, MycP 1 , MycP 2 , and MycP 3 were shown to be expressed only in the slow-growing M. bovis and M. tuberculosis species but not in the fast-growing saprophyte M. smegmatis (10) . In a subsequent study, M. tuberculosis MycP 1 was found to localize to the cell envelope and possess proteolytic activity sensitive to inhibition by serine/cysteine protease inhibitors and activation by Ca 2ϩ , properties typical of subtilisins (11) . Almost a decade later, a mycP 1 deletion mutant of M. tuberculosis was reported to be defective in ESX-1 secretion activity and attenuated for virulence (12) . In addition, the serine-protease domain of MycP 1 was found to mediate post-translational cleavage of the ESX-1-secreted protein EspB but appeared expendable for overall ESX-1 secretion activity (12) . Surprisingly however, the M. tuberculosis mycP 1 deletion mutant complemented with and expressing serine protease-dead MycP 1 displayed ESX-1-mediated hypersecretion (12) . Based on these observations, it was concluded that MycP 1 serves a dual function, with the entire protein being essential for ESX-1 activity and the serine-protease domain being required for cleaving EspB and regulating secretion (12) . MycP 5 was also found to be a functionally integral part of ESX-5, essential for M. marinum and M. bovis BCG growth and for the secretion of PE/PPE proteins (6) . Exactly how MycP 1 and MycP 5 facilitate the secretion activities of their respective ESX systems remained poorly understood.
In a recent study reported in mBio, van Winden and colleagues presented findings on M. marinum MycP 1 and MycP 5 that ad-dresses this question (13) . The authors first generated a mycP 1 deletion mutant of M. marinum and found its ESX-1 secretion activity to be completely abolished. Moreover, the mycP 1 deletion mutant was unable to mediate ESX-1-dependent lysis of erythrocytes. Complementation of the mutant with mycP 1 restored the wild-type (WT) secretion and virulence phenotype. However, complementation with a serine protease-dead version of mycP 1 (mycP 1 S354A ) resulted in the secretion of unprocessed EspB and enhanced ESX-1-mediated secretion and erythrocyte lysis (13) . They then went one step further and also complemented the mycP 1 deletion mutant with a "bulky" variant of mycP 1 (mycP 1 N239Y ), the construction of which was informed by previous structural work detailing the EspB-binding site of MycP 1 (14) . (15) . These results, taken together, confirm that the core ESX-1 and ESX-5 secretion complexes in M. marinum are similar.
Despite mass spectrometry results that indicated that MycP 1 and MycP 5 are not integral components of their respective core secretion complexes, van Winden speculated that the two proteins might still be required for their proper functioning. Comparative Blue native PAGE of cell envelope extracts from WT, mycP 5 deficient, and complemented M. marinum cells followed by immunoblotting with anti-EccB 5 antibody revealed the 1,500-kDa core ESX-5 complex to be absent in the mycP 5 This study by van Winden and colleagues is important for several reasons. First, the authors have confirmed in another slowgrowing pathogenic mycobacterium that MycP 1 does indeed perform dual roles. However, unlike MycP 1 , MycP 5 in M. marinum at least does not appear to share the same dual-function property, even though it has a conserved serine-protease domain. This may well be a reflection of or an underlying reason for the functional differences between the ESX-1 and ESX-5 systems in mycobacterial biology. Further studies to identify the substrates for MycP 5 and ascertain the role of its serine-protease domain are warranted. Additional studies should also be done to determine the consequences for M. marinum expressing protease-dead MycP 1 in hostpathogen interactions, given that in M. tuberculosis, ESX-1 hypersecretion appears to compromise the bacterium's virulence in chronic infections (12) . Second, the authors have clearly demonstrated that the core ESX-1 complex, at least in M. marinum, is composed of EccB 1 , EccCa 1 , EccCb 1 , EccD 1 , and EccE 1 . Efforts should now focus on assessing these complexes in either M. tuberculosis, M. bovis, or recombinant M. bovis BCG with a restored ESX-1 system (e.g., BCG::RD1). Third, the authors addressed how MycP 1 and MycP 5 facilitate secretion by showing that the proteins help stabilize the formation of their respective core secretion complexes. The same approaches used by these investigators might also be valuable in determining if ESX-1-associated proteins, such as EspA, EspC, EspD, and EccA 1 , are also needed to stabilize the core ESX-1 secretion complex and, in doing so, enable secretion. Finally, the van Winden et al. study nicely demonstrates how the judicious use of ESX mutants in combination with biochemical approaches can yield further insights into the functional and temporal organization of these incredibly dynamic molecular machines. Experimental schemes using these approaches will surely reveal more details about the mycobacterial ESX systems in the future. 
